4//SEC Filing
Winton Matthew 4
Accession 0000950170-25-049393
CIK 0001693011other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:29 PM ET
Size
5.0 KB
Accession
0000950170-25-049393
Insider Transaction Report
Form 4
Transactions
- Award
Common Stock
2025-03-31$0.77/sh+2,490$1,917→ 7,388 total
Footnotes (1)
- [F1]Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of October 1, 2024 through March 31, 2025. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on March 31, 2025, the last trading day of the purchase period.
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001971400
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 4:29 PM ET
- Size
- 5.0 KB